Clinical study on the effect of treatment of Amvata ( all joint pain) and effect of regular purgation ,oral intake of medicated Ghrita and Amritadi guggulu(oral medication) in the management of Amavata(RA)

A comparative clinical study on the effect of treatment as per Chikitsasutra Nitya Virechana Indukant Ghrita and Amritadi guggulu in Amavata w.s.r. to Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012511

Enrollment

Registered

2018-03-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed patients of Amavata on the basis of clinical features as per Classical Ayurveda textbook and according to criteria of ACR

Interventions

Intervention1: Group A - Chitsasutra of Amavata: Group A Langhana (Laghu Bhojana) Swedana (Valuka Sweda) and oral administration of Tikta Katu Deepana drugs like Musta Shuntthi Indrayav and Guduchi 5

Eligibility

Inclusion criteria

Inclusion criteria: Prediagnosed case of Amavata (RA) with chronicity upto 10 year Patient fit for Valuka Swedana Virechana Karma Snehapana and Basti Karma

Exclusion criteria

Exclusion criteria: Age below 16 years and above 60 years of either sex Chronicity more than 10 years Patients with severe crippling deformities extremely reduced joint space bone deformity Any associated cardiac disease pulmonary tuberculosis DM Malignant hypertension renal function impairment Patient not fit for Valuka Swedana Virechan karma snehpan and Basti Karma

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parameterTimepoint: 3 months	—

Secondary

Measure	Time frame
To find out the comparative efficacy of the treatment in different groupsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Ujwala hivale

National Institute of Ayurveda

gmangal108@gmail.com8619849011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026